Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Therapeutics and Clinical Risk Management|September 16, 2024
Time in Therapeutic Range of Unfractionated Heparin-Based Therapy in Critically Ill Patients with COVID-19 PneumoniaTereza Romanová, Filip Burša, Peter Sklienka, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|September 5, 2023
The Impact of Mechanical Energy Assessment on Mechanical Ventilation: A Comprehensive Review and Practical ApplicationFilip Burša, David Oczka, Ondřej Jor, et al.
Transfusion Medicine (Oxford, England)|October 8, 2024
A safety comparison of heparin and argatroban anticoagulation in veno-venous extracorporeal membrane oxygenation with a focus on bleedingFilip Burša, Jan Máca, Jiří Sagan, et al.
Klinicka Mikrobiologie a Infekcni Lekarstvi|May 29, 2026
[Low prevalence of viremia in COVID-19: Clinical implications]Jiří Sagan, Martin Kutěj, Tereza Romanová, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 21, 2025
Activated Partial Thromboplastin Time and Anti-IIa Monitoring in Argatroban Anticoagulation in COVID-19 Patients on Venovenous Extracorporeal Membrane OxygenationFilip Burša, Michal Frelich, Peter Sklienka, et al.
Therapeutics and Clinical Risk Management|May 19, 2025
Lessons Learned From Awake ECMO Approach in Covid-19-Related Acute Respiratory Distress Syndrome - a Scoping ReviewPeter Sklienka, Filip Burša, Michal Frelich, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|March 12, 2026
Extracorporeal cardiopulmonary resuscitation in a large tertiary center in the Czech Republic: three years' experience and future directionsFilip Burša, Michal Frelich, Peter Sklienka, et al.
Virology Journal|October 1, 2024
Convalescent anti-SARS-CoV-2 plasma for the treatment of patients with COVID-19: a retrospective study RESCOVID-19Miloš Bohoněk, Jan Máca, Jiří Sagan, et al.
Pageof 4